Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 05/05/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 158 publications

Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report.

Condition: Elderly-Onset Neuromyelitis Optica Spectrum Disorder (NMOSD) with Mutant FCGR3A Genotype
Journal: Frontiers in immunology
Treatment Used: Ofatumumab Plus Intravenous Immunoglobulin Therapy
Number of Patients: 1
Published: December 26, 2022

A Novel approach using O-CVP to treat paraneoplastic NMO spectrum disorder associated with follicular lymphoma.

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal: BMJ case reports
Treatment Used: Obinutuzumab, Cyclophosphamide, Vincristine and Prednisolone (O-CVP)
Number of Patients: 1
Published: November 15, 2022

Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review.

Condition: Aquaporin-4 IgG Neuromyelitis Optica Spectrum Disorder (NMOSD) After COVID-19 Vaccination
Journal: Journal of neuroimmunology
Treatment Used: Steroids
Number of Patients: 16
Published: November 04, 2022

MRI-negative myelitis associated with cerebral venous thrombosis after COVID-19 infection.

Condition: Transverse Myelitis and Cerebral Venous Thrombosis After COVID-19
Journal: BMJ case reports
Treatment Used: Anticoagulation and Steroids
Number of Patients: 1
Published: October 28, 2022

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.

Condition: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders (MOGADs)
Journal: Journal of neurology, neurosurgery, and psychiatry
Treatment Used: Rituximab
Number of Patients: 315
Published: October 25, 2022

Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease.

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody Disease (MOGAD)
Journal: Neurology
Treatment Used: Rituximab
Number of Patients: 111
Published: October 14, 2022

New Treatment Perspectives for Acute Relapses in Neuromyelitis Optica Spectrum Disorder.

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal: Transfusion medicine reviews
Treatment Used: Corticosteroids, Therapeutic Plasma Exchange, and Targeted Therapies
Number of Patients: 0
Published: September 24, 2022

A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders.

Condition: Neuromyelitis Optica Spectrum Disorders (NMOSDs)
Journal: Medicine
Treatment Used: Rituximab
Number of Patients: 681
Published: September 10, 2022

Autologous hematopoietic stem cell transplantation in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Treatment Used: Autologous Hematopoietic Stem Cell Transplantation (AHSCT)
Number of Patients: 39
Published: September 08, 2022

Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder.

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal: CNS drugs
Treatment Used: Inebilizumab
Number of Patients: 0
Published: September 07, 2022

Pediatric therapeutic options in autoimmune neurologic diseases.

Condition: Pediatric Autoimmune Neurological Diseases
Journal: Medicina
Treatment Used: Steroids, Immunoglobulin, or Plasmapheresis
Number of Patients: 0
Published: September 02, 2022

Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar.

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal: Multiple sclerosis and related disorders
Treatment Used: Satralizumab
Number of Patients: 83
Published: August 25, 2022
Showing 1-12 of 158

Last Updated: 05/05/2023